Patient App vs Coxevac

The Patient App from BIOTRONIK SE & Co. KG supports patients in their daily lives with a BIOTRONIK cardiac device. The app is intended for patients who want to be more active in their therapy and take responsibility for their own health. Supported implants: IPG/ICD/CRT/BIOMONITORs • Amvia Sky, Amvia Edge, Solvia Rise • Edora, Eluna, Enitra, Enticos, Epyra, Etrinsa, Evity • Acticor, Rivacor • Ilivia, Ilivia Neo, Inlexa, Intica, Intica Neo, Inventra, Iperia, Itrevia • BIOMONITOR IV, BIOMONITOR IIIm, BIOMONITOR III • Future cardiac devices As a patient, you can use these main functions of the Patient App: • Document your symptoms quickly and easily with the Patient App. • Share the documented symptoms automatically with your physician (1,2). • View the time of the last data transfer (2) from your device to the BIOTRONIK Home Monitoring® system. The app helps you to troubleshoot any data transmission issues. • You can quickly access your digital patient ID card if needed (e.g., during security check at the airport). • Check the current battery and device status of your implant, indicating if the device is working properly (2). • View data on your mean heart rate and mean heart rate at rest collected from your implanted device (2). Full functionality of the app should be accessible when the implanted device is communicating with the BIOTRONIK Home Monitoring® system. Please always consult your doctor, before you start to use the app or Home Monitoring. (1) Depending on the internet connection or app access setting in the Home Monitoring system, your doctor may not always receive your documented symptoms. BIOTRONIK Home Monitoring and Patient App are not a replacement for emergency care. PLEASE CALL YOUR LOCAL EMERGENCY NUMBER IN AN EMERGENCY. (2) Internet connection via mobile network or Wi-Fi is required. If you have any questions or feedback, please contact our support team at patientapp.support@biotronik.com

Welcome to the Coxevac calculator Use this application to estimate the losses caused by the circulation of Q fever on livestock farms, and quantify the benefits associated with controlling this disease.